Techonology

Calmune's technology platforms provide a rapid means for recovering high affinity, fully-human antibodies and to create novel antibodies with unique structural modifications for targeting hypoimmunogenic epitopes.
SEBVI™ Technology

SEBVI™ technology exploits the power of the human immune response to rapidly identify and clone fully human antibodies with potent therapeutic activity.

Using SEBVI™ technology fully human antibodies are able to be efficiently recovered from Epstein Barr virus transformed memory B cells. With this technology Calmune is able to mine the natural human immune response to routinely and rapidly isolate fully human, biologically potent antibodies.

Calmune is partnering with ribOvax to apply SEBVI™ technology for the discovery of neutralizing antibodies against a variety of infectious diseases and conditions.

SEBVI™ is a trademark of ribOvax Biotech S. A.
 
RocketTheme Joomla Templates